New medical targets for macrolides
- 1 April 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 3 (4) , 405-410
- https://doi.org/10.1517/13543784.3.4.405
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Alterations of host response by a long-term treatment of roxithromycinJournal of Antimicrobial Chemotherapy, 1993
- Macrolide antibiotics as antiinflammatory agents: Roxithromycin in an unexpected roleInflammation Research, 1993
- Newer macrolides and their potential target organismsCurrent Opinion in Infectious Diseases, 1992
- The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of miceJournal of Antimicrobial Chemotherapy, 1992
- Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac musclesAntimicrobial Agents and Chemotherapy, 1991
- Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neotrophilsJournal of Antimicrobial Chemotherapy, 1989
- Effects of erythromycin on gastrointestinal tract motilityJournal of Antimicrobial Chemotherapy, 1985
- Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycinThe American Journal of Cardiology, 1984
- A comparison of Josamycin with macrolides and related antibiotics on isolated rat atriaEuropean Journal of Pharmacology, 1982
- Depression of cardiac function by streptomycin and other antimicrobial agentsThe American Journal of Cardiology, 1970